M. Kostura

发表

A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

K. O. Elliston, Jayne Chin, J. Weidner, 1992, Nature.

Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI

M. Mathews, M. Kostura, Matthew Kostura, 1989, Molecular and cellular biology.

IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha.

J. Weidner, K. Hogquist, D. Chaplin, 1991, Journal of immunology.

Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A Novel Modulator of Bach1 Activity

J. Kassis, M. Hannink, A. Mjalli, 2014, PloS one.

Pharmacological activation of the mitochondrial stress protease OMA1 reveals a therapeutic liability in Diffuse Large B-Cell Lymphoma

A. Schambach, M. Gaestel, A. Schwarzer, 2022, European Journal of Cancer.

TTP4000, a soluble fusion protein inhibitor of Receptor for Advanced Glycation End Products (RAGE) is an effective therapy in animal models of Alzheimer's disease

M. Kindy, A. Mjalli, Bin Zhou, 2013 .

Inhibition of protein synthesis in CHO cells by actinomycin D: lesion occurs after 40S initiation complex formation.

M. Kostura, N. Craig, 1983, Biochemistry.

Interaction of adenovirus VA RNAI with the protein kinase DAI: Nonequivalence of binding and function

M. Mathews, K. Mellits, M. Kostura, 1990, Cell.

Targeting aggressive B-cell lymphomas through pharmacological activation of the mitochondrial protease OMA1

A. Schambach, A. Schwarzer, D. Weinstock, 2022, bioRxiv.

Dissociation of IL-1 beta synthesis and secretion in human blood monocytes stimulated with bacterial cell wall products.

J. Chin, M. Kostura, Matthew Kostura, 1993, Journal of immunology.

The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro

B. Stillman, M. Mathews, D. Marshak, 1987, Nature.

Probing the role of interleukin-1 beta convertase in interleukin-1 beta secretion.

A. Howard, J. Schmidt, M. Kostura, 1991, Agents and actions. Supplements.

Treatment of Chinese hamster ovary cells with the transcriptional inhibitor actinomycin D inhibits binding of messenger RNA to ribosomes.

M. Kostura, N. Craig, 1986, Biochemistry.

Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1

A. Schambach, M. Gaestel, A. Schwarzer, 2022, bioRxiv.

Functional identity of proliferating cell nuclear antigen and a DNA polymerase-δ auxiliary protein

B. Stillman, M. Mathews, K. Downey, 1987, Nature.

The interleukin-1 beta-converting enzyme (ICE) is localized on the external cell surface membranes and in the cytoplasmic ground substance of human monocytes by immuno-electron microscopy

J. Weidner, Douglas K. Miller, K. Chapman, 1995, The Journal of experimental medicine.

Identification of a monocyte specific pre-interleukin 1 beta convertase activity.

P. Cameron, J. Chin, J. Schmidt, 1989, Proceedings of the National Academy of Sciences of the United States of America.

IL-1 beta-converting enzyme is present in monocytic cells as an inactive 45-kDa precursor.

Douglas K. Miller, T. Yamin, J. Chin, 1994, Journal of immunology.

The IL‐1β Converting Enzyme as a Therapeutic Target

N. Thornberry, S. Molineaux, Douglas K. Miller, 1993 .

Identification of a 90-kDa polypeptide which associates with adenovirus VA RNAI and is phosphorylated by the double-stranded RNA-dependent protein kinase.

M. Mathews, A. Rice, M. Kostura, 1989, The Journal of biological chemistry.

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice.

A. Shaw, Howard Y. Chen, M. Kluger, 1995, Immunity.

Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase.

E. A. O'neill, J. Vacca, B. Frantz, 1999, Journal of medicinal chemistry.